Recent studies have related NfL, WMH severity and cognitive decline in CSVD [31–37]. This knowledge as well as the absent correlation of CSF NfL and AD pathology markers in our CSVD cohort (data not shown) suggests NfL as a promising diagnostic biofluid marker that distinguishes between AD and CSVD pathology. Here, NEFL is linked to Alzheimer disease.